[1]Alvarez F, Berg PA, Bianchi FB, et al.International Autoim-mune Hepatitis Group Report:review of criteriafor diagnosisof autoimmune hepatitis[J].J Hepatol, 1999, 31 (5) :929-938.
|
[2] Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis[J]. Hepatology, 2008, 48 (1) : 169-176.
|
[3] Czaja AJ. Performance Parameters of the diagnostic scoring systems for autoimmune hepatitis[J]. Hepatology, 2008, 48 (5) : 1540-1548.
|
[4]Yeoman AD, Westbrook RH, Al-Chalabi T, et al.Diagnos-tic value and utility of the simplified International AutoimmuneHepatitis Group (IAIHG) criteria in acute and chronic liverdisease[J].Hepatology, 2009, 50 (2) :538-545.
|
[5]Gatselis NK, Zachou K, Papamichalis P, et al.Comparisonof simplified score with the revised original score for the di-agnosis of autoimmune hepatitis:anew or acomplementarydiagnostic score?[J].Dig Liver Dis, 2010, 42 (11) :807-812.
|
[6]Muratori P, Granito A, Pappas G, et al.Validation of simpli-fied diagnostic criteria for autoimmune hepatitis in Italian pa-tients[J].Hepatology, 2009, 49 (5) :1782-1783.
|
[7]Qiu D, Wang Q, Wang H, et al.Validation of the simplifiedcriteria for diagnosis of autoimmune hepatitis in Chinese pa-tients[J].J Hepatol, 2011, 54 (2) :340-347.
|
[8] Miyake Y, Iwasaki Y, Kobashi H, et al. Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group[J]. Dig Liver Dis, 2010, 42 (3) : 210-215.
|
[9]Abe M, MashibaT, ZeniyaM, et al.Present status of auto-immune hepatitis in Japan:a nationwide survey[J].J Gas-troenterol, 2011 May 20.[Epub ahead of print]
|
[10]Okano N, Yamamoto K, SakaguchiK, et al.Clinicopathologi-cal features of acute-onset autoimmune hepatitis[J].Hep-atol Res, 2003, 25 (3) :263-270.
|
[11]Abe M, Onji M, Kawai-NinomiyaK, et al.Clinicopathologicfeatures of the severe form of acute type 1 autoimmune hep-atitis[J].Clin Gastroenterol Hepatol, 2007, 5 (2) :255-258.
|
[12]Bj rnsson E, Talwalkar J, Treeprasertsuk S, et al.Patientswith typicallaboratory features of autoimmune hepatitis rarelyneed aliver biopsy for diagnosis[J].Clin Gastroenterol Hep-atol, 2011, 9 (1) :57-63.
|
[1] | Wang QiXia, Ma Xiong. Current status and perspectives of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2020, 36(4): 721-723. doi: 10.3969/j.issn.1001-5256.2020.04.001 |
[2] | Wang Rui, Wang QiXia, Ma Xiong. Standard therapy and potential therapeutic targets for autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2020, 36(4): 737-742. doi: 10.3969/j.issn.1001-5256.2020.04.005 |
[3] | Jin Chao, Pan JieLu, Yu Xiao, Zhang HaiYan, Xing LianJun. Advances in the clinical treatment of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2331-2334. doi: 10.3969/j.issn.1001-5256.2019.10.044 |
[4] | Xue Mei, Shen Yi, Shen MengYi, Fan XiaoLi, Men RuoTing, Yang Li. Autoimmune hepatitis-related autoantibodies and their clinical significance[J]. Journal of Clinical Hepatology, 2019, 35(6): 1392-1396. doi: 10.3969/j.issn.1001-5256.2019.06.048 |
[5] | Chen Jie, Huang ChunYang, Dan Jing, Liu YanMin. Role of autoimmune ecological factors in the pathogenesis of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2339-2341. doi: 10.3969/j.issn.1001-5256.2019.10.046 |
[6] | Li Hai. Establishment of the diagnostic criteria and hierarchical diagnosis and treatment system for acute-on-chronic liver failure based on high-quality Chinese evidence[J]. Journal of Clinical Hepatology, 2019, 35(9): 1900-1902. doi: 10.3969/j.issn.1001-5256.2019.09.002 |
[7] | Chen Jie, Liu YanMin, Huang ChunYang, Huang YunLi, Zhang XiaoDan, Ren MeiXin, Du XiaoFei, Bian XinQu, Liao HuiYu, Han Ying, Dan Jing. Clinical features of autoimmune hepatitis in children: An analysis of 10 cases[J]. Journal of Clinical Hepatology, 2018, 34(10): 2164-2168. doi: 10.3969/j.issn.1001-5256.2018.10.020 |
[8] | Sheng JianHui, Sun Li, Tan HuiYing, Tan YouWen. Roxithromycin-induced autoimmune hepatitis:a case report[J]. Journal of Clinical Hepatology, 2018, 34(5): 1086-1087. doi: 10.3969/j.issn.1001-5256.2018.05.032 |
[9] | Hu ZhiChao, Fan XiaoLi, Shen Yi, Yang Li. Current status and recent progress of second-line drugs for autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(5): 1119-1122. doi: 10.3969/j.issn.1001-5256.2018.05.042 |
[10] | Zhang HongXia, Guo LiPing, Zhou Lu, Wang BangMao. Association between the rapidity of response and progression to cirrhosis in patients with autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(4): 820-824. doi: 10.3969/j.issn.1001-5256.2018.04.025 |
[11] | Li YanQing, Dong HongJing, Liu XiaoWen, Gao YanHang. Latest clinical advances in autoimmune hepatitis in special populations and special types of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(6): 1338-1342. doi: 10.3969/j.issn.1001-5256.2018.06.044 |
[12] | Gao XiaoQin, Zhao YongXun, Ren Qian, Zhou YongNing. Research advances in drug-induced autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2222-2225. doi: 10.3969/j.issn.1001-5256.2017.11.038 |
[13] | Zhang Dong, Zhang Tao, Wu YuNan, Sun KeWei. A systematic analysis of the application of diagnostic criteria for drug-induced liver injury in China based on the literature[J]. Journal of Clinical Hepatology, 2017, 33(5): 919-923. doi: 10.3969/j.issn.1001-5256.2017.05.026 |
[14] | Zhong QiHua, Zhou GuiQin, Wang XianBo, Wang XiaoJing, Wang RongBing, Sun FengXia. Research advances in non-hormonal therapies for autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2016, 32(2): 378-381. doi: 10.3969/j.issn.1001-5256.2016.02.040 |
[15] | Zhang Jun, Wang QiXia, Ma Xiong. Advances in immunological treatment of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2016, 32(10): 1874-1877. doi: 10.3969/j.issn.1001-5256.2016.10.010 |
[16] | Wang QianYi, Jia JiDong. Advances in diagnosis and treatment of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2015, 31(2): 160-162. doi: 10.3969/j.issn.1001-5256.2015.02.003 |
[17] | Lu Jun. Three cases of drug-induced autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2014, 30(5): 449-450. doi: 10.3969/j.issn.1001-5256.2014.05.017 |
[18] | Li Bing, Shao Qing, Niu XiaoXia, Zhang Jian, Chen GuoFeng. Clinical features and diagnosis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome[J]. Journal of Clinical Hepatology, 2014, 30(5): 413-416. doi: 10.3969/j.issn.1001-5256.2014.05.007 |
[19] | Qiu DeKai. Diagnosis and treatment of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(5): 321-322. |
[20] | Wang TaiLing, Zhao XinYan. Pathological features of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2011, 27(6): 577-580. |